McCune-Albright syndrome (MAS) is a sporadic disease characterized by fibrous bone dysplasia, café-au-lait spots and hyperfunctional endocrinopathies. We report a 2.5-year-old child with MAS with an early and nonclassic onset. He was admitted to our attention for frequent fractures without clinical signs of endocrinopathies, found to have asymptomatic, nonautoimmune hyperthyroidism. The diagnosis of MAS was based on RX and MR imaging associated with hyperthyroidism. It is not clear if there was a correlation between the severity of bone disease and the presence of thyroid disorder. At the moment no standard treatment exists for bone fibrous dysplasia and hyperthyroidism in children before the age of 6 years.

Keywords:
McCune-Albright syndrome, Hyperthyroidism, Fractures, Fibrous dysplasia, Pigmentation, Pamidronate treatment
1.
Shenker A, Weinstein LS, Moran A, Pescvitz OH, Charest NJ, Boney CM, Van Wyk JJ, Merino MJ, Feuillan CM, Spiegel AM: Severe endocrine and nonendocrine manifestation of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J Pediatr 1993;123:509–518.
2.
Rimiucci M, Fisher LW, Shenker A, Spiegel M, Bianco P, Robey PG: Fibrous dysplasia of bone in the McCune-Albright syndrome. Abnormalities in bone formation. Am J Pathol 1997;151:1587–1600.
3.
De Sanctis C, Lala R, Matarazzo P, Balsamo A, Bergamaschi R, Cappa M, Cisternino M, de Sanctis V, Lucci M, Franzese A, Ghizzoni L, Pasquino M, Segni AM, Rigon F, Saggese G, Betelloni S, Buzi F: McCune-Albright syndrome: A longitudinal clinical study of 32 patients. J Pediatr Endocrinol Metab 1999;12:817–826.
4.
Mastorakos G, Mitsiades NS, Doufas AG, Koutras DA: Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 1997;7:433–439.
5.
Feuillan PP, Shawer T, Rose SR, Jones J, Jeevanram RK, Nisula BC: Thyroid abnormalities in the McCune-Albright syndrome: Ultrasonography and hormonal studies. J Clin Endocrinol Metab 1990;71:1596–1601.
6.
Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C: Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Pediatr 2000;89:188–193.
7.
Foley TP Jr: Management of Graves’ disease in childhood and the role of radioiodine treatment. Abstracts Book: New Developments in Pediatric Thyroidology. Symposium Session, ENDO 82nd Annual Meeting, Toronto, June 21–24, 2000.
8.
Mora S, Weber G, Marenzi K, Signorini E, Rovelli R, Proverbio MC, Chiumello G: Longitudinal changes of bone density and resorption in hyperthyroid girls during treatment. J Bone Miner Res 1999;14:1971–1977.
9.
Palit TK, Miller CC, Miltenburg DM: The efficacy of thyroidectomy for Graves’ disease: A meta-analysis. J Surg Res 2000;90:161–165.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.